Dr. Rohit K. Katial, MD
Allergy & Immunology (Allergy & Immunology Physician)
- Medicare participating
At a glance
- Medical school
- Georgetown University School of Medicine (1991)
- Years since graduation
- 35
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 117
Licensed in Colorado since 2002, according to the Colorado Department of Regulatory Agencies. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1991Medical school: Georgetown University School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Allergy & Immunology Physician primary
CO license 40918 (first issued 2002; active) -
Clinical & Laboratory Immunology (Allergy & Immunology) Physician
CO license 40918 (first issued 2002; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- University of Colorado Hospital Authority Aurora, CO
- National Jewish Health Denver, CO
Medical groups
- National Jewish Health (247 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 117
- Services billed
- 156
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 74 | 48 |
| New patient office or other outpatient visit, 60-74 minutes | 56 | 56 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Symbicort (budesonide/formoterol fumarate) Other prescribers in Denver, CO | 26 |
| Dupixent Pen (dupilumab) Other prescribers in Denver, CO | 23 |
| Fasenra Pen (benralizumab) | 15 |
| Ipratropium Bromide Other prescribers in Denver, CO | 15 |
| Advair Hfa (fluticasone propion/salmeterol) Other prescribers in Denver, CO | 12 |
| Azelastine-Fluticasone (azelastine/fluticasone) | 11 |
| Dupixent Syringe (dupilumab) Other prescribers in Denver, CO | 11 |
| Arnuity Ellipta (fluticasone furoate) Other prescribers in Denver, CO | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 12 companies reported 217 payments worth $252,015 in total to this clinician.
| AstraZeneca Pharmaceuticals LP | $155,175 |
|---|---|
| Regeneron Healthcare Solutions, Inc. | $32,340 |
| Genzyme Corporation | $28,093 |
| Novartis Pharmaceuticals Corporation | $10,583 |
| Grifols USA, LLC | $6,147 |
| AstraZeneca UK Limited | $6,115 |
| Regeneron Pharmaceuticals, Inc. | $4,194 |
| GlaxoSmithKline, LLC. | $3,272 |
| Compensation for services other than consulting (speaking, faculty) | $135,362 |
|---|---|
| Consulting Fee | $81,798 |
| Travel and Lodging | $30,195 |
| Food and Beverage | $4,640 |
| Education | $19.31 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation May 2, 2025 | Consulting Fee | $9,200 |
| Regeneron Healthcare Solutions, Inc. Jun 4, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $8,738 |
| Genzyme Corporation May 30, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $8,738 |
| Genzyme Corporation Apr 26, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $8,388 |
| AstraZeneca Pharmaceuticals LP Apr 15, 2025 | Consulting Fee FASENRA · Respiratory Company’s descriptionResearch Related Service | $6,825 |
| AstraZeneca Pharmaceuticals LP Apr 15, 2025 | Consulting Fee FASENRA · Respiratory Company’s descriptionResearch Related Service | $6,175 |
| Regeneron Healthcare Solutions, Inc. Aug 29, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $5,942 |
| AstraZeneca Pharmaceuticals LP Nov 13, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $5,600 |
| AstraZeneca Pharmaceuticals LP Apr 15, 2025 | Consulting Fee FASENRA · Respiratory Company’s descriptionResearch Related Service | $5,200 |
| AstraZeneca Pharmaceuticals LP Mar 3, 2025 | Compensation for services other than consulting (speaking, faculty) FASENRA · Respiratory Company’s descriptionSpeaker Fee | $5,200 |
All 149 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP Dec 11, 2025 | Consulting Fee AIRSUPRA · Respiratory | $1,950 |
| Genzyme Corporation Dec 2, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $3,623 |
| AstraZeneca Pharmaceuticals LP Dec 1, 2025 | Consulting Fee FASENRA · Respiratory | $2,061 |
| AstraZeneca Pharmaceuticals LP Nov 24, 2025 | Compensation for services other than consulting (speaking, faculty) AIRSUPRA · Respiratory Company’s descriptionSpeaker Fee | $1,400 |
| AstraZeneca Pharmaceuticals LP Nov 24, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $450 |
| Grifols USA, LLC Nov 21, 2025 | Compensation for services other than consulting (speaking, faculty) Xembify · Immunology and Neurology | $4,990 |
| Grifols USA, LLC Nov 21, 2025 | Travel and Lodging Xembify · Immunology and Neurology · travel to Baltimore, MD · in-kind | $490 |
| Grifols USA, LLC Nov 21, 2025 | Travel and Lodging Xembify · Immunology and Neurology · travel to Baltimore, MD · in-kind | $322 |
| Grifols USA, LLC Nov 21, 2025 | Travel and Lodging Xembify · Immunology and Neurology · travel to Baltimore, MD | $249 |
| AstraZeneca Pharmaceuticals LP Nov 21, 2025 | Travel and Lodging AIRSUPRA · Respiratory · travel to Orlando, FL Company’s descriptionConsulting Expenses | $27.80 |
| AstraZeneca Pharmaceuticals LP Nov 13, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $5,600 |
| AstraZeneca Pharmaceuticals LP Nov 8, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Orlando, FL · in-kind Company’s descriptionSpeaker Expenses | $366 |
| AstraZeneca Pharmaceuticals LP Nov 8, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Orlando, FL · in-kind Company’s descriptionSpeaker Expenses | $209 |
| AstraZeneca Pharmaceuticals LP Nov 6, 2025 | Consulting Fee FASENRA · Respiratory | $2,223 |
| AstraZeneca Pharmaceuticals LP Oct 28, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $5,200 |
| AstraZeneca Pharmaceuticals LP Oct 12, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Indianapolis, IN · in-kind Company’s descriptionSpeaker Expenses | $604 |
| AstraZeneca Pharmaceuticals LP Oct 12, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Indianapolis, IN · in-kind Company’s descriptionSpeaker Expenses | $467 |
| AstraZeneca Pharmaceuticals LP Oct 12, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Indianapolis, IN · in-kind Company’s descriptionSpeaker Expenses | $177 |
| AstraZeneca Pharmaceuticals LP Oct 12, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Indianapolis, IN · in-kind Company’s descriptionSpeaker Expenses | $29.25 |
| AstraZeneca Pharmaceuticals LP Oct 9, 2025 | Consulting FeeCompany’s descriptionResearch Related Service | $650 |
| AstraZeneca Pharmaceuticals LP Oct 6, 2025 | Compensation for services other than consulting (speaking, faculty) FASENRA · Respiratory Company’s descriptionSpeaker Fee | $5,200 |
| AstraZeneca Pharmaceuticals LP Oct 4, 2025 | Travel and Lodging FASENRA · Respiratory · travel to Edina, MN · in-kind Company’s descriptionSpeaker Expenses | $272 |
| AstraZeneca Pharmaceuticals LP Oct 4, 2025 | Travel and Lodging FASENRA · Respiratory · travel to Edina, MN · in-kind Company’s descriptionSpeaker Expenses | $257 |
| AstraZeneca Pharmaceuticals LP Oct 4, 2025 | Travel and Lodging FASENRA · Respiratory · travel to Edina, MN · in-kind Company’s descriptionSpeaker Expenses | $188 |
| AstraZeneca Pharmaceuticals LP Oct 2, 2025 | Compensation for services other than consulting (speaking, faculty) FASENRA · Respiratory Company’s descriptionSpeaker Fee | $3,250 |
| AstraZeneca Pharmaceuticals LP Oct 1, 2025 | Consulting Fee TEZSPIRE · Respiratory | $975 |
| AstraZeneca Pharmaceuticals LP Sep 25, 2025 | Travel and Lodging FASENRA · Respiratory · travel to Aurora, CO · in-kind Company’s descriptionSpeaker Expenses | $46.35 |
| AstraZeneca Pharmaceuticals LP Sep 24, 2025 | Travel and Lodging BREZTRI · Respiratory · travel to Dallas, TX Company’s descriptionConsulting Expenses | $92.00 |
| AstraZeneca Pharmaceuticals LP Sep 24, 2025 | Travel and Lodging BREZTRI · Respiratory · travel to Dallas, TX Company’s descriptionConsulting Expenses | $63.00 |
| AstraZeneca Pharmaceuticals LP Sep 23, 2025 | Compensation for services other than consulting (speaking, faculty) FASENRA · Respiratory Company’s descriptionSpeaker Fee | $125 |
| AstraZeneca Pharmaceuticals LP Sep 23, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $125 |
| AstraZeneca Pharmaceuticals LP Sep 22, 2025 | Consulting Fee BREZTRI · Respiratory | $2,600 |
| AstraZeneca Pharmaceuticals LP Sep 21, 2025 | Consulting Fee FASENRA · Respiratory | $2,600 |
| AstraZeneca Pharmaceuticals LP Sep 18, 2025 | Consulting Fee | $2,600 |
| AstraZeneca Pharmaceuticals LP Sep 18, 2025 | Consulting FeeCompany’s descriptionResearch Related Service | $650 |
| AstraZeneca Pharmaceuticals LP Sep 12, 2025 | Travel and Lodging BREZTRI · Respiratory · travel to Dallas, TX · in-kind Company’s descriptionSpeaker Expenses | $524 |
| AstraZeneca Pharmaceuticals LP Sep 12, 2025 | Travel and Lodging BREZTRI · Respiratory · travel to Dallas, TX · in-kind Company’s descriptionSpeaker Expenses | $284 |
| AstraZeneca Pharmaceuticals LP Sep 12, 2025 | Travel and Lodging BREZTRI · Respiratory · travel to Dallas, TX · in-kind Company’s descriptionSpeaker Expenses | $161 |
| Genzyme Corporation Sep 11, 2025 | Consulting Fee | $2,864 |
| Regeneron Healthcare Solutions, Inc. Aug 29, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $5,942 |
| AstraZeneca Pharmaceuticals LP Aug 29, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $1,300 |
| AbbVie Inc. Aug 21, 2025 | Consulting Fee | $675 |
| AstraZeneca Pharmaceuticals LP Aug 19, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $5,200 |
| AstraZeneca Pharmaceuticals LP Aug 19, 2025 | Compensation for services other than consulting (speaking, faculty) FASENRA · Respiratory Company’s descriptionSpeaker Fee | $125 |
| Regeneron Healthcare Solutions, Inc. Aug 15, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to FORT COLLINS, CO · in-kind | $963 |
| AstraZeneca Pharmaceuticals LP Aug 12, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $250 |
| AstraZeneca Pharmaceuticals LP Aug 5, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $250 |
| AstraZeneca Pharmaceuticals LP Aug 4, 2025 | Compensation for services other than consulting (speaking, faculty) FASENRA · Respiratory Company’s descriptionSpeaker Fee | $5,200 |
| AstraZeneca Pharmaceuticals LP Jul 31, 2025 | Travel and Lodging FASENRA · Respiratory · travel to Dana Point, CA · in-kind Company’s descriptionSpeaker Expenses | $497 |
| AstraZeneca Pharmaceuticals LP Jul 31, 2025 | Travel and Lodging FASENRA · Respiratory · travel to Dana Point, CA · in-kind Company’s descriptionSpeaker Expenses | $413 |
| AstraZeneca Pharmaceuticals LP Jul 31, 2025 | Travel and Lodging FASENRA · Respiratory · travel to Dana Point, CA · in-kind Company’s descriptionSpeaker Expenses | $233 |
| AstraZeneca Pharmaceuticals LP Jul 24, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Aspen, CO · in-kind Company’s descriptionSpeaker Expenses | $568 |
| AstraZeneca Pharmaceuticals LP Jul 24, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Aspen, CO · in-kind Company’s descriptionSpeaker Expenses | $259 |
| AstraZeneca Pharmaceuticals LP Jul 18, 2025 | Consulting Fee FASENRA · Respiratory Company’s descriptionResearch Related Service | $975 |
| AstraZeneca Pharmaceuticals LP Jul 16, 2025 | Compensation for services other than consulting (speaking, faculty) FASENRA · Respiratory Company’s descriptionSpeaker Fee | $125 |
| AstraZeneca Pharmaceuticals LP Jul 8, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $100 |
| Regeneron Healthcare Solutions, Inc. Jun 24, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to HONOLULU, HI · in-kind | $376 |
| Regeneron Healthcare Solutions, Inc. Jun 24, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to HONOLULU, HI · in-kind | $72.97 |
| AstraZeneca Pharmaceuticals LP Jun 18, 2025 | Compensation for services other than consulting (speaking, faculty) FASENRA · Respiratory Company’s descriptionSpeaker Fee | $1,300 |
| Regeneron Healthcare Solutions, Inc. Jun 6, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $1,049 |
| Regeneron Healthcare Solutions, Inc. Jun 4, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $8,738 |
| Regeneron Healthcare Solutions, Inc. Jun 4, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $3,146 |
| Regeneron Healthcare Solutions, Inc. Jun 3, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to HONOLULU, HI · in-kind | $410 |
| Genzyme Corporation May 30, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $8,738 |
| Genzyme Corporation May 30, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Honolulu, HI · in-kind | $492 |
| Regeneron Healthcare Solutions, Inc. May 30, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to HONOLULU, HI · in-kind | $267 |
| Genzyme Corporation May 30, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Honolulu, HI | $78.91 |
| AstraZeneca Pharmaceuticals LP May 29, 2025 | Compensation for services other than consulting (speaking, faculty) AIRSUPRA · Respiratory Company’s descriptionSpeaker Fee | $250 |
| AstraZeneca Pharmaceuticals LP May 28, 2025 | Consulting Fee FASENRA · Respiratory | $650 |
| Novartis Pharmaceuticals Corporation May 2, 2025 | Consulting Fee | $9,200 |
| Novartis Pharmaceuticals Corporation May 2, 2025 | Travel and Lodging travel to EAST HANOVER, NJ | $343 |
| Novartis Pharmaceuticals Corporation May 2, 2025 | Travel and Lodging travel to EAST HANOVER, NJ · in-kind | $228 |
| Novartis Pharmaceuticals Corporation May 2, 2025 | Travel and Lodging travel to EAST HANOVER, NJ · in-kind | $16.00 |
| Novartis Pharmaceuticals Corporation May 2, 2025 | Travel and Lodging travel to EAST HANOVER, NJ · in-kind | $11.00 |
| Novartis Pharmaceuticals Corporation May 1, 2025 | Travel and Lodging travel to Whippany, NJ · in-kind | $438 |
| Novartis Pharmaceuticals Corporation May 1, 2025 | Travel and Lodging travel to Whippany, NJ · in-kind | $81.71 |
| AstraZeneca Pharmaceuticals LP May 1, 2025 | Travel and Lodging FASENRA · Respiratory · travel to Berlin, Germany Company’s descriptionResearch Related Service | $75.86 |
| Novartis Pharmaceuticals Corporation May 1, 2025 | Education in-kind | $19.31 |
| Grifols Shared Services North America, Inc. Apr 30, 2025 | Compensation for services other than consulting (speaking, faculty) Xembify · Immunology and Neurology | $713 |
| AstraZeneca Pharmaceuticals LP Apr 29, 2025 | Compensation for services other than consulting (speaking, faculty) FASENRA · Respiratory Company’s descriptionSpeaker Fee | $5,200 |
| AstraZeneca Pharmaceuticals LP Apr 29, 2025 | Compensation for services other than consulting (speaking, faculty) FASENRA · Respiratory Company’s descriptionSpeaker Fee | $1,950 |
| AstraZeneca Pharmaceuticals LP Apr 29, 2025 | Compensation for services other than consulting (speaking, faculty) AIRSUPRA · Respiratory Company’s descriptionSpeaker Fee | $1,950 |
| Genzyme Corporation Apr 26, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $8,388 |
| Genzyme Corporation Apr 26, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to San Francisco, CA · in-kind | $837 |
| Genzyme Corporation Apr 26, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to San Francisco, CA · in-kind | $254 |
| Genzyme Corporation Apr 26, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to San Francisco, CA | $199 |
| Genzyme Corporation Apr 26, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to San Francisco, CA | $22.37 |
| AstraZeneca Pharmaceuticals LP Apr 25, 2025 | Consulting Fee FASENRA · Respiratory Company’s descriptionResearch Related Service | $975 |
| AstraZeneca Pharmaceuticals LP Apr 25, 2025 | Consulting FeeCompany’s descriptionResearch Related Service | $650 |
| AstraZeneca Pharmaceuticals LP Apr 24, 2025 | Travel and Lodging FASENRA · Respiratory · travel to Houston, TX · in-kind Company’s descriptionSpeaker Expenses | $818 |
| AstraZeneca Pharmaceuticals LP Apr 24, 2025 | Travel and Lodging FASENRA · Respiratory · travel to Houston, TX · in-kind Company’s descriptionSpeaker Expenses | $258 |
| Regeneron Healthcare Solutions, Inc. Apr 23, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to HONOLULU, HI · in-kind | $3,691 |
| AstraZeneca Pharmaceuticals LP Apr 23, 2025 | Compensation for services other than consulting (speaking, faculty) FASENRA · Respiratory Company’s descriptionSpeaker Fee | $1,950 |
| AstraZeneca Pharmaceuticals LP Apr 21, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $5,200 |
| AstraZeneca Pharmaceuticals LP Apr 18, 2025 | Compensation for services other than consulting (speaking, faculty) FASENRA · Respiratory Company’s descriptionSpeaker Fee | $5,200 |
| AstraZeneca Pharmaceuticals LP Apr 16, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $4,550 |
| AstraZeneca Pharmaceuticals LP Apr 16, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Grapevine, TX · in-kind Company’s descriptionSpeaker Expenses | $288 |
| AstraZeneca Pharmaceuticals LP Apr 16, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Grapevine, TX · in-kind Company’s descriptionSpeaker Expenses | $232 |
| AstraZeneca Pharmaceuticals LP Apr 16, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Grapevine, TX · in-kind Company’s descriptionSpeaker Expenses | $231 |
| AstraZeneca Pharmaceuticals LP Apr 15, 2025 | Consulting Fee FASENRA · Respiratory Company’s descriptionResearch Related Service | $6,825 |
| AstraZeneca Pharmaceuticals LP Apr 15, 2025 | Consulting Fee FASENRA · Respiratory Company’s descriptionResearch Related Service | $6,175 |
| AstraZeneca Pharmaceuticals LP Apr 15, 2025 | Consulting Fee FASENRA · Respiratory Company’s descriptionResearch Related Service | $5,200 |
| Regeneron Healthcare Solutions, Inc. Apr 15, 2025 | Compensation for services other than consulting (speaking, faculty) | $2,295 |
| Regeneron Healthcare Solutions, Inc. Apr 15, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $2,167 |
| AstraZeneca Pharmaceuticals LP Apr 15, 2025 | Consulting Fee AIRSUPRA · Respiratory | $975 |
| AstraZeneca Pharmaceuticals LP Apr 14, 2025 | Consulting Fee FASENRA · Respiratory Company’s descriptionResearch Related Service | $4,388 |
| AstraZeneca Pharmaceuticals LP Apr 14, 2025 | Consulting Fee FASENRA · Respiratory Company’s descriptionResearch Related Service | $3,575 |
| AstraZeneca Pharmaceuticals LP Apr 11, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $5,200 |
| AstraZeneca Pharmaceuticals LP Apr 10, 2025 | Travel and Lodging FASENRA · Respiratory · travel to Wyndmoor, PA · in-kind Company’s descriptionSpeaker Expenses | $867 |
| AstraZeneca Pharmaceuticals LP Apr 10, 2025 | Travel and Lodging FASENRA · Respiratory · travel to Wyndmoor, PA · in-kind Company’s descriptionSpeaker Expenses | $648 |
| AstraZeneca Pharmaceuticals LP Apr 10, 2025 | Travel and Lodging FASENRA · Respiratory · travel to Philadelphia, PA · in-kind Company’s descriptionSpeaker Expenses | $350 |
| AstraZeneca Pharmaceuticals LP Apr 10, 2025 | Travel and Lodging FASENRA · Respiratory · travel to Wyndmoor, PA · in-kind Company’s descriptionSpeaker Expenses | $250 |
| AstraZeneca Pharmaceuticals LP Apr 9, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $2,600 |
| AstraZeneca Pharmaceuticals LP Apr 7, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $5,200 |
| GlaxoSmithKline, LLC. Apr 7, 2025 | Consulting Fee | $2,600 |
| AstraZeneca Pharmaceuticals LP Apr 7, 2025 | Compensation for services other than consulting (speaking, faculty) FASENRA · Respiratory Company’s descriptionSpeaker Fee | $125 |
| AstraZeneca Pharmaceuticals LP Apr 3, 2025 | Consulting Fee FASENRA · Respiratory Company’s descriptionResearch Related Service | $4,063 |
| AstraZeneca Pharmaceuticals LP Apr 2, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Monterey, CA · in-kind Company’s descriptionSpeaker Expenses | $465 |
| AstraZeneca Pharmaceuticals LP Apr 2, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Monterey, CA · in-kind Company’s descriptionSpeaker Expenses | $399 |
| AstraZeneca Pharmaceuticals LP Apr 2, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Monterey, CA · in-kind Company’s descriptionSpeaker Expenses | $383 |
| GlaxoSmithKline, LLC. Apr 2, 2025 | Travel and Lodging travel to Castle Rock, CO | $382 |
| GlaxoSmithKline, LLC. Apr 2, 2025 | Travel and Lodging travel to Castle Rock, CO | $63.00 |
| Genzyme Corporation Apr 1, 2025 | Consulting Fee | $2,070 |
| AstraZeneca Pharmaceuticals LP Apr 1, 2025 | Compensation for services other than consulting (speaking, faculty) FASENRA · Respiratory Company’s descriptionSpeaker Fee | $100 |
| Genzyme Corporation Apr 1, 2025 | Travel and Lodging travel to Denver, CO | $25.90 |
| AstraZeneca Pharmaceuticals LP Mar 29, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Washington, DC · in-kind Company’s descriptionSpeaker Expenses | $925 |
| AstraZeneca Pharmaceuticals LP Mar 29, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Washington, DC · in-kind Company’s descriptionSpeaker Expenses | $522 |
| AstraZeneca Pharmaceuticals LP Mar 29, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Washington, DC · in-kind Company’s descriptionSpeaker Expenses | $222 |
| AstraZeneca Pharmaceuticals LP Mar 24, 2025 | Consulting FeeCompany’s descriptionResearch Related Service | $650 |
| Regeneron Healthcare Solutions, Inc. Mar 21, 2025 | Consulting Fee DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $2,097 |
| Regeneron Healthcare Solutions, Inc. Mar 21, 2025 | Consulting Fee DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $699 |
| AstraZeneca UK Limited Mar 18, 2025 | Travel and Lodging FASENRA · Respiratory · travel to Berlin, Germany · in-kind Company’s descriptionResearch Related Service | $5,127 |
| AstraZeneca UK Limited Mar 18, 2025 | Travel and Lodging FASENRA · Respiratory · travel to Berlin, Germany · in-kind Company’s descriptionResearch Related Service | $222 |
| AstraZeneca UK Limited Mar 18, 2025 | Travel and Lodging FASENRA · Respiratory · travel to Berlin, Germany · in-kind Company’s descriptionResearch Related Service | $222 |
| AstraZeneca UK Limited Mar 18, 2025 | Travel and Lodging FASENRA · Respiratory · travel to Berlin, Germany · in-kind Company’s descriptionResearch Related Service | $213 |
| AstraZeneca UK Limited Mar 18, 2025 | Travel and Lodging FASENRA · Respiratory · travel to Berlin, Germany · in-kind Company’s descriptionResearch Related Service | $64.70 |
| Takeda Pharmaceuticals U.S.A., Inc. Mar 13, 2025 | Consulting Fee TAKHZYRO · GENETIC DISEASE | $1,691 |
| AstraZeneca Pharmaceuticals LP Mar 13, 2025 | Consulting FeeCompany’s descriptionResearch Related Service | $650 |
| Amgen Inc. Mar 4, 2025 | Consulting Fee | $3,000 |
| AstraZeneca Pharmaceuticals LP Mar 4, 2025 | Compensation for services other than consulting (speaking, faculty) AIRSUPRA · Respiratory Company’s descriptionSpeaker Fee | $250 |
| AstraZeneca Pharmaceuticals LP Mar 3, 2025 | Compensation for services other than consulting (speaking, faculty) FASENRA · Respiratory Company’s descriptionSpeaker Fee | $5,200 |
| AstraZeneca Pharmaceuticals LP Mar 3, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $5,200 |
| AstraZeneca Pharmaceuticals LP Mar 2, 2025 | Travel and Lodging travel to Philadelphia, PA Company’s descriptionConsulting Expenses | $160 |
| AstraZeneca Pharmaceuticals LP Mar 2, 2025 | Travel and Lodging travel to Philadelphia, PA Company’s descriptionConsulting Expenses | $60.30 |
| AstraZeneca Pharmaceuticals LP Feb 11, 2025 | Travel and Lodging TEZSPIRE · Respiratory · travel to Kohala Coast, HI · in-kind Company’s descriptionSpeaker Expenses | $1,142 |
| AstraZeneca Pharmaceuticals LP Jan 20, 2025 | Consulting Fee FASENRA · Respiratory | $650 |
| Regeneron Pharmaceuticals, Inc. Jan 17, 2025 | Consulting Fee DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $2,796 |
| Regeneron Pharmaceuticals, Inc. Jan 17, 2025 | Consulting Fee DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $1,398 |
| AstraZeneca Pharmaceuticals LP Jan 6, 2025 | Compensation for services other than consulting (speaking, faculty) TEZSPIRE · Respiratory Company’s descriptionSpeaker Fee | $250 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 3 industry-funded studies in 2025, from 2 companies. The companies reported $100,911 in research payments for these studies, mostly to the institutions running them.
- Multicenter, prospective, open-label, randomized, crossover study to evaluate the pharmacokinetics (pk), safety, tolerability of TAK-881-3001 in primary immunodeficiency diseases (pidd)
Takeda Pharmaceuticals U.S.A., Inc. - Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma
Regeneron Pharmaceuticals, Inc. · Active, not recruiting · NCT06572228 - Long-term safety and tolerability of TAK-881 in subjects with primary immunodeficiency diseases (pidd)
Takeda Pharmaceuticals U.S.A., Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.